Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper.

@article{Zinzani2016CriticalCP,
  title={Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper.},
  author={P L Zinzani and P. Poggi – Corradini and Maurizio Martelli and Giorgio Minotti and Stefano Oliva and Michele Spina and Giovanni Barosi and Sante Tura},
  journal={European journal of haematology},
  year={2016},
  volume={97 6},
  pages={554-561}
}
OBJECTIVES In this paper, we present a review of critical concepts and research perspectives and produce recommendations on the optimal use of pixantrone in non-Hodgkin lymphoma (NHL) by group discussion from an expert panel appointed by the Italian Society of Hematology and the affiliate societies, Società Italiana di Ematologia Sperimentale and Gruppo Italiano Trapianto di Midollo Osseo. METHODS Recommendations were produced using the Delphi process. Scientific evidence on pixantrone… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology • 2013
View 6 Excerpts
Highly Influenced

Pixantrone dimaleate for treating nonHodgkin’s lymphoma

R Pettengell, J. Kaur
Expert Opin Orphan Drugs • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…